x

Search for a clinical trial

* (*) mandatory field

7 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

ITALY

LOMBARDIA
MILANO

Multicenter randomised double blind placebo controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A - IT
Fondazione IRCCS Istituto Neurologico "Carlo Besta"
Clinica Neuropatie Degenerative Centrali e Periferiche

NETHERLANDS

Noord-Holland
AMSTERDAM

Ascorbic Acid Treatment in CMT1A Trial (AATIC) (Phase II)
AMC - Academisch Medisch Centrum
Afdeling Neurologie

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Study of the effect of Bi-001 (ascorbic acid) on muscle strength in patients with Charcot-Marie-Tooth 1 A (Phase II)
CHU de Marseille - Hôpital de la Timone
Centre de pharmacologie clinique et d'évaluation thérapeutique

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

UNITED KINGDOM

Greater London
LONDON

CMT-TRAUK: Randomised double blind placebo controlled trial of long term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (Phase III) (Completed)
National Hospital for Neurology and Neurosurgery
MRC Centre for Neuromuscular Disease and Department of Molecular Neurosciences